Kari Ashmont, Ph.D. is the Translational Team Lead at the National Institute of Biomedical Imaging and Bioengineering (NIBIB). She joined NIBIB in 2022 and manages the NIBIB Small Business Programs, including the Concept to Clinic: Commercializing Innovation (C3i) Program, and supports the institute’s RADx® Tech programs. Additionally, Dr. Ashmont co-leads the Dissemination Programs for the NIH BRAIN Initiative.

Previously, Dr. Ashmont was a Program Director at the National Institute of Neurological Disorders and Stroke (NINDS) where she oversaw translational device cooperative agreements and ran the NIH Blueprint for Neuroscience Research Education Program on Translational Devices (R25). Prior to joining the NINDS in 2017, Dr. Ashmont was a postdoctoral researcher at Phoenix Children’s Hospital, where her work focused on using engineering approaches and technology to improve clinical care and diagnostics, particularly in pediatric epilepsy and traumatic brain injury. As a graduate student, Dr. Ashmont developed a novel seizure detection algorithm and worked on projects involving micro-stimulation capabilities for cortical visual prosthetics and sensory discriminability. She received Bachelor of Science degrees in Mechanical Engineering and Biology from Clarkson University and both a Master of Science and Doctor of Philosophy degree in Biomedical Engineering from Arizona State University.